Searched for
EXELTIS
Lupin inks distribution pact with 3 firms to commercialise NaMuscla in EuropeExeltis Healthcare SL, Cresco Pharma BV and Macure Pharma ApS will commercialise NaMuscla for the symptomatic treatment of myotonia in adul...03 Jun, 2020, 01.18 PM IST- New product launches will continue to drive growth: Glenn Saldanha, GlenmarkOur EBITDA margins continue to be about 17 plus per cent, says Glenmark Pharma CMD18 Feb, 2019, 10.27 AM IST
Load More